BIOMAT Database Logo BIOMAT Database Logo

Chemotherapy and immunotherapy for malignant melanoma. 1980

S P Richman, and J U Gutterman, and E M Hersh

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

S P Richman, and J U Gutterman, and E M Hersh
[Immunotherapy for malignant melanoma].
July 2020, Der Internist,
S P Richman, and J U Gutterman, and E M Hersh
Immunotherapy for malignant melanoma.
May 2012, Current stem cell research & therapy,
S P Richman, and J U Gutterman, and E M Hersh
Immunotherapy for human malignant melanoma.
April 1975, Southern medical journal,
S P Richman, and J U Gutterman, and E M Hersh
Malignant melanoma and immunotherapy.
October 1976, British medical journal,
S P Richman, and J U Gutterman, and E M Hersh
Local active immunotherapy for malignant melanoma.
January 1975, Panminerva medica,
S P Richman, and J U Gutterman, and E M Hersh
Adjuvant BCG immunotherapy for malignant melanoma.
October 1984, Canadian Medical Association journal,
S P Richman, and J U Gutterman, and E M Hersh
[Adjuvant chemo-immunotherapy for malignant melanoma].
January 1978, Haematology and blood transfusion,
S P Richman, and J U Gutterman, and E M Hersh
Adjuvant immunotherapy for vulvar malignant melanoma.
January 1979, The Mount Sinai journal of medicine, New York,
S P Richman, and J U Gutterman, and E M Hersh
Systemic chemotherapy for malignant melanoma.
January 1992, World journal of surgery,
S P Richman, and J U Gutterman, and E M Hersh
Chemotherapy for advanced malignant melanoma.
January 1992, International journal of clinical & laboratory research,
Copied contents to your clipboard!